Signal2026-06-10
ClinicalTrials.gov

[PHASE3] Efficacy in Relapse Prevention: Psilocybin in Alcohol Use Disorder With Depressive Symptoms

Part of

Advancing Psychedelic And Novel Therapeutics

Open primary sourceSee the whole picture